Tracking generalized pustular psoriasis in Costa Rica
Part of Skin clinical trials.
This study is a registry in Costa Rica that collects information about people diagnosed with generalized pustular psoriasis (GPP). It helps doctors learn more about this rare skin condition and how it affects patients over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of GPP from a skin doctor.
- Your GPP diagnosis is recorded in your medical records at the hospital.
- You receive care at a participating hospital in Costa Rica's public health system.
- You agree to have your medical information used for this study.
- You have enough medical history available for the researchers to review.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry tracks the safety and effectiveness of GPP treatments in real-world settings. It helps doctors and researchers learn how well current and future medicines work for people with generalized pustular psoriasis.
This study tests an experimental drug called HB0034 for people with a sudden, severe flare of generalized pustular psoriasis (GPP). It aims to see if the drug can safely clear the pustules and improve symptoms.
This study looks at how psoriasis affects children in Costa Rica, including what treatments they receive. It helps doctors understand the condition better and improve care for kids with psoriasis.
This study is a registry that collects information from patients with psoriatic disease who are treated with IL-23 inhibitors (guselkumab or risankizumab) in Costa Rica. It aims to track how these treatments work in real-life settings to improve care.
This study looks at people with Hansen's disease (leprosy) in Costa Rica to understand how it affects them and how it's treated. By joining, you help researchers learn more about this condition to improve care for others.
This study looks at how well two types of advanced medicines—dupilumab and JAK inhibitors—work for people with moderate to severe eczema in Costa Rica. It uses information from your regular doctor visits to see how these treatments help.
Hear when a new Generalized Pustular Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.